Atherectomy Devices Market Opportunities, Competitive Landscape & Forecast, 2026-2035

Ngày đăng: 05-08-2026 | Ngày cập nhật: 05-08-2026

Atherectomy Devices Market Outlook and Forecast

The Atherectomy Devices Market is witnessing steady growth as healthcare providers increasingly adopt minimally invasive technologies for the treatment of peripheral artery disease (PAD), coronary artery disease (CAD), and other vascular disorders. Atherectomy procedures offer effective plaque removal while preserving healthy blood vessels, reducing the need for open surgical interventions and supporting faster patient recovery. The growing prevalence of cardiovascular diseases, aging populations, increasing incidence of diabetes and obesity, and rising awareness regarding early vascular intervention continue to drive market expansion. Technological advancements in imaging-guided procedures and next-generation atherectomy systems are further improving treatment precision and clinical outcomes.

In 2025, the Atherectomy Devices Market was valued at USD 1.08 Billion and is projected to reach USD 2.35 Billion by 2035, growing at a CAGR of 8.1% during 2026–2035. North America remains the dominant regional market due to high cardiovascular disease prevalence, advanced healthcare infrastructure, widespread adoption of minimally invasive procedures, and favorable reimbursement policies. Europe continues to experience stable market growth supported by increasing investments in vascular care and expanding adoption of advanced interventional cardiology technologies. Asia Pacific is expected to register the fastest growth owing to improving healthcare infrastructure, rising healthcare expenditure, increasing patient awareness, and growing demand for advanced cardiovascular treatments across emerging economies.

Among product segments, Directional Atherectomy held the leading position in 2025, accounting for a 38.05% share of the atherectomy devices market due to its effectiveness in plaque removal and broad clinical application. Meanwhile, Laser Atherectomy is emerging as the fastest-growing segment as healthcare providers increasingly adopt laser-assisted technologies that enable precise lesion treatment while minimizing vessel trauma.

Request Free Sample Report @ https://www.fundamentalbusinessinsights.com/request-sample/14597

Top Market Trends

Growing Preference for Minimally Invasive Cardiovascular Procedures

The increasing demand for minimally invasive vascular interventions continues to accelerate adoption of atherectomy devices worldwide. Compared to traditional surgical approaches, atherectomy procedures offer shorter hospital stays, lower complication rates, faster recovery, and improved patient outcomes. Healthcare providers are increasingly integrating these technologies into routine treatment protocols for peripheral and coronary artery diseases.

Technological Advancements in Atherectomy Systems

Manufacturers are investing heavily in advanced atherectomy platforms featuring improved catheter flexibility, enhanced plaque removal efficiency, integrated imaging compatibility, and superior navigation capabilities. These innovations enable physicians to perform more precise interventions while reducing procedural complexity and improving treatment safety across diverse patient populations.

Increasing Integration with Intravascular Imaging

The use of intravascular ultrasound (IVUS), optical coherence tomography (OCT), and advanced imaging technologies alongside atherectomy procedures is becoming increasingly common. Real-time imaging improves lesion assessment, procedural planning, and treatment accuracy, allowing physicians to optimize plaque removal while minimizing procedural risks and improving long-term clinical outcomes.

Expansion of Ambulatory and Specialized Vascular Centers

The growth of outpatient cardiovascular centers and specialized vascular clinics is creating new opportunities for atherectomy device manufacturers. Improvements in procedural efficiency, compact equipment designs, and minimally invasive techniques are enabling a broader range of vascular interventions to be performed outside traditional hospital settings while reducing overall healthcare costs.

Request Free Sample Report @ https://www.fundamentalbusinessinsights.com/request-sample/14597

Recent Company Developments

Abbott Laboratories continued expanding its vascular intervention portfolio through product innovation initiatives focused on improving treatment precision and supporting complex peripheral artery disease procedures.

Boston Scientific Corporation strengthened its atherectomy portfolio by investing in advanced interventional technologies and physician education programs designed to improve clinical outcomes in vascular interventions.

Medtronic plc continued advancing minimally invasive cardiovascular technologies through research and development efforts aimed at improving procedural efficiency and expanding treatment capabilities.

Cardiovascular Systems, Inc. (CSI) focused on enhancing orbital atherectomy technologies while expanding physician training initiatives to support greater adoption of advanced plaque modification procedures.

Philips continued integrating advanced imaging technologies with interventional cardiovascular solutions to improve procedural planning, treatment precision, and patient outcomes.

Terumo Corporation expanded its vascular intervention product portfolio through continued investment in catheter-based technologies and minimally invasive cardiovascular treatment solutions.

Becton, Dickinson and Company (BD) strengthened its peripheral intervention business by developing innovative vascular access and treatment technologies that complement atherectomy procedures.

Avinger, Inc. continued enhancing image-guided atherectomy technologies with product improvements designed to increase treatment precision and simplify physician workflow during vascular procedures.

Royal Philips expanded collaborations with healthcare providers to strengthen adoption of integrated imaging-guided vascular treatment platforms supporting minimally invasive cardiovascular care.

Cardinal Health continued expanding distribution capabilities and supporting healthcare facilities with comprehensive interventional cardiovascular product portfolios that include advanced vascular treatment technologies.

Related Reports

About Fundamental Business Insights

Fundamental Business Insights is a global market research and consulting company engaged in providing in-depth market intelligence to industrial sectors, financial institutions, universities, non-profit organizations, and corporations. The company is committed to delivering accurate information to the right stakeholders at the right time in a format that enables logical and informed decision-making. With an experienced team of consultants, Fundamental Business Insights offers syndicated market studies, customized research reports, and strategic consulting services designed to address evolving industry requirements.